BIOTRONIK and MiCare Path Announce First-of-Its-Kind Partnership

MEMPHIS, Tenn. - EntSun -- BIOTRONIK, a global leader in cardiac monitoring technology, is proud to announce a new partnership with MiCare Path, a pioneer in digital health solutions, to deliver a comprehensive Remote Physiologic Monitoring (RPM) program for cardiology practices. This collaboration is designed to empower clinics to seamlessly extend care beyond the office visit, driving improved patient outcomes.

BIOTRONIK's BIOMONITOR IV insertable cardiac monitor (ICM) devices can now be combined with a MiCare Path RPM device. The package features either a cellular-enabled blood pressure monitor or weight scale, and a patient mobile app that provides clinics with a turnkey solution to launch or expand their cardiac RPM programs. This integration supports both patients with BIOMONITOR IV devices and the broader clinical cardiology network.

More on EntSun News

• Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
• Beneficial Bang of YHL Young Hustle League Announces New EP Enemy Of The State
• The Southland Symphony Orchestra & Chorus presents "Trouble & Triumph"
• South Philadelphia Filmmakers Launch Fourth Feature Film on Amazon Prime Video
• Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA

This collaboration underscores the dedication of both organizations to deliver best-in-class solutions that simplify clinical workflows while enhancing patient engagement and satisfaction. By combining BIOTRONIK's proven cardiac monitoring technology with MiCare Path's scalable RPM platform, clinics are equipped to deliver comprehensive, data-driven care for today's cardiac patients.

"This partnership represents the next evolution in personalized cardiac care," said Ryan Walters, President of BIOTRONIK, Inc. "MiCare Path's innovative approach to virtual care complements our mission of delivering excellence for life. Together, we are giving providers new tools to see the whole picture so they can act faster with greater confidence, helping patients live healthier, longer lives."

"Our customers have been asking for deeper insight, broader coverage, and smarter care – this cooperation comes as a direct response to these," said Scott Laster, CEO of MiCare Path. "We're proud to work alongside the team at BIOTRONIK, whose reputation for precision and clinical commitment is unmatched in the industry."

More on EntSun News

• 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
• 9th Annual Baton Rouge Soul Food Festival Cooking Contest Now Open to Entrants
• Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
• Evening With Jim: Jim Jarmusch on Rebel Without A Cause (Documentary) Arrives on DVD in 2026
• Dwayne Buckle: 20 Years of Filmmaking 2005–2025 (Documentary) Arrives on DVD in 2026

BIOTRONIK has built a reputation for engineering excellence, reliability, and a relentless dedication to patient outcomes. With presence in more than 100 countries and over 60 years of medical innovation with an outstanding quality record, BIOTRONIK empowers physicians with technologies that support timely decision-making, patient safety, and long-term clinical success. This partnership further extends BIOTRONIK's vision for a connected and patient-centered future.

Over the past six years, MiCare Path has deployed its virtual care platform to tens of thousands of patients nationwide, enabling providers to extend care beyond the office visit through remote monitoring, chronic and principal care management, and intelligent real-time alerts. The integration with BIOMONITOR IV allows care teams to track arrhythmias and cardiac events more comprehensively, delivering peace of mind to both clinicians and patients.

For more information, visit http://www.biotronik.com or http://www.micarepath.com.